VINFLUNINE Side Effects

5676133-9 | Cardiomyopathy
on Mar 11, 2008 Female patient from FRANCE , 64 years of age, was diagnosed with breast cancer metastatic and was treated with Vinflunine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiomyopathy (What is cardiomyopathy?). Vinflunine dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ATACAND (View Atacand Review and Atacand Label ), BRUFEN (View Brufen Review and Brufen Label ), TOREM (View Torem Review and Torem Label ).

5593394-5 | Abdominal Pain, Bone Marrow Failure, Constipation, Headache, Ileus Paralytic, Nausea
Patient was taking Vinflunine (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), bone marrow failure, constipation (What is constipation?), headache (What is headache?), ileus paralytic, nausea (What is nausea?) on Jan 10, 2008 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 165.3 lb, was diagnosed with non-small cell lung cancer, prophylaxis and. Vinflunine dosage: Expiry Date For Lot Number 7c33262- 31mar2009. Vinflunine 320mg/m2. During the same period patient was treated with CETUXIMAB (Treatment Taken Also On 19-nov-2007.) (View Cetuximab Review and Cetuximab Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VICODIN (View Vicodin Review and Vicodin Label ), VITAMIN (View Vitamin Review and Vitamin Label ), ALEVE (View Aleve Review and Aleve Label ). Patient was hospitalized.

5526628-3 | Abdominal Pain, Bone Marrow Failure, Constipation, Headache, Ileus Paralytic, Nausea
Adverse event was reported on Nov 20, 2007 by a Female patient taking Vinflunine (View Usage) (Dosage: Expiry Date For Lot Number 7c33262- 31mar2009. Vinflunine 320mg/m2) was diagnosed with non-small cell lung cancer, prophylaxis and. Location: UNITED STATES , 72 years of age, weighting 165.3 lb, After Vinflunine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), bone marrow failure, constipation (What is constipation?), headache (What is headache?), ileus paralytic, nausea (What is nausea?). During the same period patient was treated with CETUXIMAB (View Cetuximab Review and Cetuximab Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), CALCIUM (View Calcium Review and Calcium Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VICODIN (View Vicodin Review and Vicodin Label ), VITAMIN (View Vitamin Review and Vitamin Label ), ALEVE (View Aleve Review and Aleve Label ). Patient was hospitalized.

5340259-X | Hypoaesthesia
on May 30, 2007 Male patient from UNITED STATES , 62 years of age, was diagnosed with transitional cell carcinoma and was treated with Vinflunine (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia. Vinflunine dosage: . During the same period patient was treated with METAMINE (View Metamine Review and Metamine Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ).


5313430-0 | Constipation
on Apr 25, 2007 Female patient from FRANCE , 69 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Vinflunine (View Usage). Patient had the following side effects: constipation (What is constipation?). Vinflunine dosage: . During the same period patient was treated with GEMZAR (View Gemzar Review and Gemzar Label ), ZOFRAN (View Zofran Review and Zofran Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), FORLAX (View Forlax Review and Forlax Label ).

5280192-5 | Aspiration Pleural Cavity Abnormal, Atrial Fibrillation, Crepitations, Dyspnoea, Haematemesis, Haematocrit Decreased, Haemoptysis, Heart Rate Increased, Hypotension
Patient was taking Vinflunine (View Usage). After Vinflunine was administered, patient had the following side effects: aspiration pleural cavity abnormal, atrial fibrillation (What is atrial fibrillation?), crepitations, dyspnoea, haematemesis, haematocrit decreased, haemoptysis, heart rate increased, hypotension on Mar 26, 2007 from UNITED STATES Additional patient health information: Female patient , 60 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and. Vinflunine dosage: 320mg/m2 Q3wk Iv. During the same period patient was treated with CETUXIMAB (250mg/m2 Weekly Iv) (View Cetuximab Review and Cetuximab Label ). Patient was hospitalized.

5278532-6 | Abdominal Discomfort, Faecal Incontinence, Neutropenia, Urinary Retention
Adverse event was reported on Mar 16, 2007 by a Female patient taking Vinflunine (View Usage) (Dosage: ) was diagnosed with breast cancer metastatic and. Location: FRANCE , 78 years of age, Patient experienced the following unwanted or unexpected effects: abdominal discomfort, faecal incontinence, neutropenia, urinary retention. During the same period patient was treated with EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ). Patient was hospitalized.

4940024-9 | Gastritis, Ileus, Malignant Hypertension, Neutropenia, Septic Shock, Thrombocytopenia, Urosepsis
on Feb 01, 2006 Male patient from UNITED STATES , 70 years of age, was diagnosed with neoplasm malignant and was treated with Vinflunine (View Usage). Patient had the following side effects: gastritis, ileus, malignant hypertension, neutropenia, septic shock, thrombocytopenia, urosepsis. Vinflunine dosage: . During the same period patient was treated with KETOCONAZOLE (View Ketoconazole Review and Ketoconazole Label ), DIOVAN (View Diovan Review and Diovan Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), AMBIEN (View Ambien Review and Ambien Label ). Patient was hospitalized.

4907788-1 | Ileus, Mental Impairment
on Feb 01, 2006 Male patient from UNITED STATES , 70 years of age, was treated with Vinflunine (View Usage). After Vinflunine was administered, patient had the following side effects: ileus, mental impairment. Vinflunine dosage: . During the same period patient was treated with KETOCONAZOLE (View Ketoconazole Review and Ketoconazole Label ). Patient was hospitalized.

4906441-8 | Ileus, Mental Impairment, Sepsis
Patient was taking Vinflunine (View Usage). Patient experienced the following unwanted or unexpected effects: ileus, mental impairment, sepsis (What is sepsis?) on Feb 01, 2006 from UNITED STATES Additional patient health information: Male patient , 70 years of age, . Vinflunine dosage: . During the same period patient was treated with KETOCONAZOLE (View Ketoconazole Review and Ketoconazole Label ). Patient was hospitalized.

4816648-6 | Anorexia, Asthenia, Condition Aggravated, Dehydration, Diarrhoea, Hypokalaemia, Hyponatraemia, Neutropenia
Adverse event was reported on Apr 29, 2003 by a Male patient taking Vinflunine (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer and. Location: FRANCE , 71 years of age, weighting 178.6 lb, Patient had the following side effects: anorexia, asthenia, condition aggravated, dehydration, diarrhoea, hypokalaemia, hyponatraemia, neutropenia. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

4793693-0 | Constipation, Vomiting
on Sep 30, 2005 Female patient from FRANCE , 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Vinflunine (View Usage). After Vinflunine was administered, patient had the following side effects: constipation (What is constipation?), vomiting. Vinflunine dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

4783526-0 | Abdominal Pain, Constipation, Fatigue
on Sep 19, 2005 Male patient from FRANCE , 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Vinflunine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), constipation (What is constipation?), fatigue. Vinflunine dosage: Actual Dose: 554 Mg.. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), DIMETHICONE (View Dimethicone Review and Dimethicone Label ), DIPYRONE TAB (5 Ml/2.5 Grams.) (View Dipyrone Tab Review and Dipyrone Tab Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), SODIUM CHLORIDE (0.9%.) (View Sodium Chloride Review and Sodium Chloride Label ). Patient was hospitalized.

4783404-7 | Abdominal Pain, Nausea
Patient was taking Vinflunine (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), nausea (What is nausea?) on Sep 19, 2005 from FRANCE Additional patient health information: Female patient , 52 years of age, was diagnosed with non-small cell lung cancer and. Vinflunine dosage: Actual Dose: 496 Mg. Dose Reduced To 280 Mg/m2 For Cycle 2 On 25-sep-2002.. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), AMINOPHYLLINE (View Aminophylline Review and Aminophylline Label ), KETONAL (View Ketonal Review and Ketonal Label ), RANIGAST (View Ranigast Review and Ranigast Label ). Patient was hospitalized.

4723396-X | Cardiomyopathy
Adverse event was reported on Jun 22, 2005 by a Female patient taking Vinflunine (View Usage) (Dosage: ) was diagnosed with breast cancer metastatic and. Location: FRANCE , 64 years of age, After Vinflunine was administered, patient had the following side effects: cardiomyopathy (What is cardiomyopathy?). During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ATACAND (View Atacand Review and Atacand Label ), BRUFEN (View Brufen Review and Brufen Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ).

4713030-7 | Cardiomyopathy
on Jun 22, 2005 Female patient from FRANCE , 64 years of age, was diagnosed with breast cancer metastatic and was treated with Vinflunine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiomyopathy (What is cardiomyopathy?). Vinflunine dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ATACAND (View Atacand Review and Atacand Label ), BRUFEN (View Brufen Review and Brufen Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ).

4704228-2 | Cardiomyopathy
on Jun 22, 2005 Female patient from , 64 years of age, was diagnosed with breast cancer metastatic and was treated with Vinflunine (View Usage). Patient had the following side effects: cardiomyopathy (What is cardiomyopathy?). Vinflunine dosage: . During the same period patient was treated with DOXORUBICIN (View Doxorubicin Review and Doxorubicin Label ), ATACAND (View Atacand Review and Atacand Label ), BRUFEN (View Brufen Review and Brufen Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ).